Cargando…
Limitations and lessons in the use of X-ray structural information in drug design
The use of X-ray crystal structure models continues to provide a strong stimulus to drug discovery, through the direct visualisation of ligand–receptor interactions. There is sometimes a limited appreciation of the uncertainties introduced during the process of deriving an atomic model from the expe...
Autores principales: | Davis, Andrew M., St-Gallay, Stephen A., Kleywegt, Gerard J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185550/ https://www.ncbi.nlm.nih.gov/pubmed/18617015 http://dx.doi.org/10.1016/j.drudis.2008.06.006 |
Ejemplares similares
-
Validation of ligands in macromolecular structures determined by X-ray crystallography
por: Smart, Oliver S., et al.
Publicado: (2018) -
Implementing an X-ray validation pipeline for the Protein Data Bank
por: Gore, Swanand, et al.
Publicado: (2012) -
X-ray diffraction tomography with limited projection information
por: Zhu, Zheyuan, et al.
Publicado: (2018) -
Data-deposition protocols for correlative soft X-ray tomography and super-resolution structured illumination microscopy applications
por: Iudin, Andrii, et al.
Publicado: (2021) -
X-ray structure and inhibition of the feline infectious peritonitis virus 3C-like protease: Structural implications for drug design
por: St. John, Sarah E., et al.
Publicado: (2015)